Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
221 results found
Jan 11, 2018
Poster
RSV
Antigenic Characterization of RSV Pre-fusogenic F Nanoparticle Vaccine, Pre-F, and Post-F Proteins against a Broad Range of Neutralizing Monoclonal Antibodies and Epitope Responses in Cotton Rats

11th International Respiratory Syncytial Virus Symposium

Patel, Nita
View/Download
Sep 21, 2017
Publication
Collaborative
Vaccine
Malaria, Matrix-M® adjuvant
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
Venkatraman, Navin, Anagnostou, Nicholas , Bliss, Carly, et al.
View
Aug 22, 2017
Publication
Novavax led
Vaccine
Seasonal influenza, Matrix-M® adjuvant
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
Smith, Gale, Liu, Ye, Flyer, David, et al.
View
Aug 10, 2017
Publication
Collaborative
PLOS ONE
RSV
The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review
Colosia, Ann D., Yang, Jin, Hillson, Eric, et al.
View
Jun 1, 2017
Publication
Novavax led
Vaccine
RSV
A Phase 2 Randomized, Observer-blind, Placebo-controlled, Dose-ranging trial of Aluminum-Adjuvanted Respiratory Syncytial Virus F Particle Vaccine Formulations in Healthy Women of Childbearing Age
August, Allison, Glenn, Gregory M. , Kpamegan, Eloi, et al.
View
Apr 12, 2017
Publication
Novavax led
Immunity & Ageing
RSV
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Fries, Louis , Shinde, Vivek, Stoddard, Jeffrey J., et al.
View
May 25, 2016
Presentation
RSV, Matrix-M® adjuvant
Recombinant Nanoparticle Vaccines: Respiratory and Emerging Viruses

Keystone Symposia: New Approaches to Vaccines for Human and Veterinary Tropical Disease

Fries, Louis
View/Download
Feb 24, 2016
Publication
Novavax led
Ebola, Matrix-M® adjuvant
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
View
Nov 9, 2015
Presentation
Ebola
Rapid Responses to Novel Lethal Viruses: The Potential of Recombinant Nanoparticle Vaccines Produced in Sf9 Insect Cells

World Vaccine Congress

Glenn, Gregory, et al.
View/Download
Oct 9, 2015
Presentation
Ebola
Novavax Ebola/Makona Glycoprotein (GP) Nanoparticle Vaccine Candidate Update: NHP and Clinical Data

WHO 5th Teleconference on Ebola Vaccine Clinical Trials

View/Download